Travere Therapeutics (TVTX) Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase
Go back to Travere Therapeutics (TVTX) Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase| (NASDAQ: TVTX) | Delayed: 55.11 -0.04 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.15 | 52 Week High | $ | |||
| Open | $56.20 | 52 Week Low | $ | |||
| Day High | $56.81 | P/E | N/A | |||
| Day Low | $55.00 | EPS | $ | |||
| Volume | 1,742,522 | |||||
